The UCLA Institute for Precision Health (IPH) serves as a nexus for interdisciplinary collaboration across the David Geffen School of Medicine (DGSOM), UCLA Health System and the University. In 2016, in collaboration with the Clinical and Translational Science Institute (CTSI), the IPH launched the ATLAS Community Health Initiative (ATLAS) to engage a diverse sample of patients across UCLA Health in precision health research. The goal was to create a powerful and robust clinical and genomic data resource for cutting-edge translational research. ATLAS aims to enroll at least 150,000 patients into the UCLA Precision Health Biobank. Genetic information from this large-scale collection of diverse patient biospecimens is integrated with de-identified clinical information from the patient medical record and made available to UCLA approved researchers. To access samples or data click here to submit a request.
How to participate?
UCLA Health is committed to help patients make an informed decision about participating in the UCLA ATLAS Community Health Initiative. UCLA Patients who are interested in completing the Universal Consent may click here to learn more and explore different ways to participate. In addition, patients who visit any of our participating locations can complete the Universal Consent on an ipad offered upon check-in. Before signing the consent, our participants view a short video outlining the goal of the initiative and document their choice. As the bio-samples become available for patients who have opted-in to participate in the UCLA ATLAS Community Health Initiative, the UCLA ATLAS Precision Health Biobank picks up samples and de-identifies them for DNA extraction and genotyping.
Participate in the UCLA ATLAS Community Health Initiative. Watch our Universal Consent Video below and participate here!